Form D · Biotechnology
Capstan Therapeutics, Inc.
San Diego, CA · CIK 0002015437
Offering snapshot reported Mar 20, 2024 · SEC filing
- Reported sold
- $87.5M Offering amount: $175M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 5, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2024 | Initial | $87,499,982 | No comparison | 21 | SEC filing |
| Mar 20, 2024 | Initial | $76,499,983 | No comparison | 14 | SEC filing |
| Mar 20, 2024 | Initial | $62,999,992 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508077
Source: Form D, filed Mar 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Baran | Director |
| Adrian Bot | Executive |
| Erez Chimovits | Director |
| Athena Countouriotis | Director |
| Ramin Farzaneh Far | Executive |
| Rajul Jain | Director |
| Priya Karmali | Executive |
| Nanna Luneborg | Director |
| Fabio Pucci | Director |
| Nandita Shangari | Director |
| Laura Shawver | Director, Executive |
| Michal Silverberg | Director |
| Karen Smith | Director |
| Justin Thacker | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9880 Campus Point Drive, Suite 220
San Diego, CA, 92121
San Diego, CA, 92121